Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Daily News

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

Caitlin E. Cox

March 18, 2021

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

ILUMIEN I 发布：OCT 能够影响 PCI 策略

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

L.A. McKeown

August 17, 2015

News Daily News

Tras PCI, las Hemorragias Graves Predicen una Mayor Mortalidad sobre todo el Pacientes Anémicos

February 26, 2014

News Daily News

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

February 26, 2014

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

Advertisement

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

No Stents in STEMI? With Careful Selection, Maybe

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

ILUMIEN I 发布：OCT 能够影响 PCI 策略

ILUMIEN I Published: OCT Can Affect PCI Strategy

ILUMIEN I Publicado: La TCO puede Influir en la Estrategia PCI

Tras PCI, las Hemorragias Graves Predicen una Mayor Mortalidad sobre todo el Pacientes Anémicos

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content